Is 'Normal' Normal in Cancer Genomics?
Dr. Maurie Markman considers how 'normal' genetic variants can influence cancer treatment outcome. (Source: Medscape Pathology and Laboratory Medicine Podcast)
Source: Medscape Pathology and Laboratory Medicine Podcast - December 3, 2013 Category: Laboratory Medicine Authors: Medscape Source Type: podcasts
TWiV 260: Badgers go viral
Host: Vincent Racaniello
Guests: Tom Friedrich, Tony Goldberg, and David O'Connor
Vincent visits the University of Wisconsin, Madison and speaks with Tom, Tony, and David about their work on virus discovery at the AIDS Vaccine Research Laboratory.
Links for this episode
A tick in Tony's nose (Am J Trop Med Hyg)
Two new SIV from colobus monkeys in Uganda (Biomed Cent)
Pegivirus diversity in Uganda (J Gen Virol)
Simian hemorrhagic fever virus diversity in African primates (J Virol)
Video of this episode - coming soon
Send your virology questions and comments (email or mp3 f...
Source: This Week in Virology - MP3 Edition - November 24, 2013 Category: Virology Authors: Vincent Racaniello Source Type: podcasts
Creative Disruption? She's 29 and Set to Reboot Lab Medicine
A 29-year-old Stanford dropout has developed a new biotechnology that threatens to give laboratory medicine its biggest shakeup in decades. (Source: Medscape Transplantation Podcast)
Source: Medscape Transplantation Podcast - November 18, 2013 Category: Transplant Surgery Authors: Medscape Source Type: podcasts
Dazed and Confused About Molecular Data?
Is molecular profiling integral to choice of treatment or simply a source of confusion? Dr. John Marshall speaks to issues that need to be resolved before 'personalized medicine' is practice-ready. (Source: Medscape Pathology and Laboratory Medicine Podcast)
Source: Medscape Pathology and Laboratory Medicine Podcast - October 23, 2013 Category: Laboratory Medicine Authors: Medscape Source Type: podcasts
New ALK Agents: Lung Cancer's 'Second Miracle'?
Drs. D. Ross Camidge and Giorgio Scagliotti highlight the emerging data in ALK-positive lung cancer that will change the playing field in clinical practice. (Source: Medscape Pathology and Laboratory Medicine Podcast)
Source: Medscape Pathology and Laboratory Medicine Podcast - October 7, 2013 Category: Laboratory Medicine Authors: Medscape Source Type: podcasts
TKI Hikes Survival in Recurrent Ovarian Cancer
Cediranib, bevacizumab, and novel antiangiogenic agents continue to improve survival in first-line and recurrent ovarian cancer, as reported by Dr. Stanley Kaye from ECC 2013. (Source: Medscape Pathology and Laboratory Medicine Podcast)
Source: Medscape Pathology and Laboratory Medicine Podcast - October 4, 2013 Category: Laboratory Medicine Authors: Medscape Source Type: podcasts
The 'Darkest Year Ever' for the NIH?
American Psychiatric Association President Dr. Jeffrey Lieberman on how government policies are out of sync with our country ' s medical needs. (Source: Medscape Pathology and Laboratory Medicine Podcast)
Source: Medscape Pathology and Laboratory Medicine Podcast - October 3, 2013 Category: Laboratory Medicine Authors: Medscape Source Type: podcasts
Panitumumab: Casting a Wider Net for Improved Response
Dr. David Kerr reports on a study indicating that widening the search for RAS mutants other than exon 2 can exclude a further 17% of patients with CRC who will not benefit from panitumumab. (Source: Medscape Pathology and Laboratory Medicine Podcast)
Source: Medscape Pathology and Laboratory Medicine Podcast - October 1, 2013 Category: Laboratory Medicine Authors: Medscape Source Type: podcasts
CIGNA Restricts Coverage of Genetic Testing
Dr. Kathy Miller reports on the potential harm that may come as a result of CIGNA's new policy that no genetic testing will be covered unless the patient first sees a genetic counselor. (Source: Medscape Pathology and Laboratory Medicine Podcast)
Source: Medscape Pathology and Laboratory Medicine Podcast - September 16, 2013 Category: Laboratory Medicine Authors: Medscape Source Type: podcasts
CIGNA Restricts Coverage of Genetic Testing
Dr. Kathy Miller reports on the potential harm that may come as a result of CIGNA ' s new policy that no genetic testing will be covered unless the patient first sees a genetic counselor. (Source: Medscape Pathology and Laboratory Medicine Podcast)
Source: Medscape Pathology and Laboratory Medicine Podcast - September 16, 2013 Category: Laboratory Medicine Authors: Medscape Source Type: podcasts
Dr. Gulley Discusses Vaccine Responses
James L. Gulley, MD, PhD, Head, Clinical Trials Group, Deputy Laboratory Chief, National Cancer Institute, discusses measuring response to vaccines.
More on PROSTVAC and prostate cancer: http://www......
Author: onclivetv
Added: 09/10/2013 (Source: Oncology Tube)
Source: Oncology Tube - September 10, 2013 Category: Cancer & Oncology Source Type: podcasts
'Do As I Do: Take Aspirin Daily ’
The evidence for the benefits of low-dose aspirin in primary and secondary prevention of colorectal cancer is so compelling that it has convinced CRC specialist Dr. David Kerr to take 100 mg daily. (Source: Medscape Pathology and Laboratory Medicine Podcast)
Source: Medscape Pathology and Laboratory Medicine Podcast - August 30, 2013 Category: Laboratory Medicine Authors: Medscape Source Type: podcasts
Cancer? Not!
What's in a word? Enough to 'set your hair on fire' if the word is cancer, says Dr. George Lundberg, who comments on the importance of not calling a lesion 'cancer' when it is not. (Source: Medscape Pathology and Laboratory Medicine Podcast)
Source: Medscape Pathology and Laboratory Medicine Podcast - August 29, 2013 Category: Laboratory Medicine Authors: Medscape Source Type: podcasts
